Barbut, Jack (Novimmune 201012–201512 CEO until 12/15) |
Chief Executive Officer (CEO) |
Novimmune S.A. |
Plan-les-Ouates GE |
Fleurant, Mylène (Novimmune 201609– Global Head of Quality before Alvotech + Novartis Pharma + Merck Serono) |
Chief Financial Officer (CFO) |
Novimmune S.A. |
Plan-les-Ouates GE |
Holdener, Eduard (Ed) (Novimmune 201512– CEO before Roche CMO) |
Chief Executive Officer (CEO) |
Novimmune S.A. |
Plan-les-Ouates GE |
Mills, Adrian (Novimmune 201409– CBO before GSK since 2000) |
Chief Business Officer (CBO) |
Novimmune S.A. |
Plan-les-Ouates GE |
Slack, David (Novimmune 201402 Head Corporate + Business Development LEFT 9/14) |
Business Development Manager / Strategy Manager |
Novimmune S.A. |
Plan-les-Ouates GE |
Zimmermann, Sven (Novimmune 201609– CFO before Auris Medical + PregLem + UBS Investment Bank) |
Chief Financial Officer (CFO) |
Novimmune S.A. |
Plan-les-Ouates GE |
Adams, Timothy M. (Tim) (ObsEva 201701– CFO located in US before Demandware + athenahealth + Cytyc) |
Chief Financial Officer (CFO) |
ObsEva (Group) |
Plan-les-Ouates GE |
Gotteland, Jean-Pierre (ObsEva 201701 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
ObsEva (Group) |
Plan-les-Ouates GE |
Loumaye, Ernest (ObsEva 201211– CEO + Co-founder before PregLem SA CEO + founder + Ipsen + Serono) |
Chief Executive Officer (CEO) |
ObsEva (Group) |
Plan-les-Ouates GE |
Tan, Ben T.G. (ObsEva 201409– VP Commercial + BusDev before Evolva + Novartis/Speedel + Organon + Roche) |
Business Development Manager / Strategy Manager |
ObsEva (Group) |
Plan-les-Ouates GE |
Verwiel, Frank (ObsEva 2016– Board Director before CEO of Aptalis Pharma) |
n. a. |
ObsEva (Group) |
Plan-les-Ouates GE |
Gauthier, Louie-Anne (Oculs 202105 CP Strategic Marketing + BD&L) |
Sales Manager / Marketing Manager |
Oculis (Group) |
Lausanne VD |
Sherif, Riad (Oculis 201801– CEO before Novartis Area President EMEA at Alcon) |
Chief Executive Officer (CEO) |
Oculis (Group) |
Lausanne VD |
Draetta, Francesco (Omega Funds 202010 Principal) |
Principal (venture capital) |
Omega Funds (Group) |
Boston, MA |
Graney, Tom (Oxurion 202105– CEO joined as CFO 10/20 before Generation Bio + Vertex Pharma + Ironwood Pharma + JnJ) |
Chief Executive Officer (CEO) |
Oxurion (Group) |
Leuven (Louvain) |
Manore, Hadar (Paragon Conventions 201304 Project Manager – Industry Liaison) |
Event Manager / Conference Manager |
Paragon (IL) (Group) |
Genève (Geneva) GE |
Martin, Jacques-François (Parteurop Pharma 201602 President + Founder before Mymetics + Chiron Vaccines) |
Chief Executive Officer (CEO) |
Parteurop Pharma (FR) |
Lyon |
Post, James (PHC 202002 President of Epredia) |
President/Director/Head Business Group/Unit/Division |
PHC (Group) |
Portsmouth, NH |
Sjöström, Michael |
n. a. |
Pictet (Group) |
Genève (Geneva) GE |
Hall, Matthew (SimplicityBio SA 201610 CSO + Co-Founder) |
n. a. |
Precision for Medicine (US) |
Monthey VS |
Ovaskainen, Jari |
n. a. |
Preon Capital (family office of Jari Ovaskainen) |
Genève (Geneva) GE |
Wojcik, Jérôme (Quartz Bio 201209– CEO + founder) |
Chief Executive Officer (CEO) |
Quartz Bio S.A. |
Plan-les-Ouates GE |
Behar, Greg (Recipharm 202401– CEO before CEO of Nestlé Health Science before Novartis + Boehringer Ingelheim) |
Chief Executive Officer (CEO) |
Recipharm (Group) |
Jordbro |
Fisch, Igor (NewBiologix 202305 CEO + Co-Founder before Selexis CEO + co-founder) |
Chief Executive Officer (CEO) |
Recipharm (Group) |
Epalinges VD |
Hédou, Gaël (Relief Therapeutics 201610 COO) |
Chief Operating Officer (COO) |
Relief Therapeutics (Group) |
Genève (Geneva) GE |
Selvaraju, Raghuram (Ram) (Relief Therapeutics 202010 Board Chairman) |
Board member, non-executive |
Relief Therapeutics (Group) |
Genève (Geneva) GE |
Weinstein, Jack (Relief Therapeutics 202010– CFO before Avalon Group + Catalyst Pharmaceuticals + Sterlington Group) |
Chief Financial Officer (CFO) |
Relief Therapeutics (Group) |
Genève (Geneva) GE |
Kucera, Tomas (Saphetor 201912 Head of Business Development) |
Business Development Manager / Strategy Manager |
Saphetor S.A. (VarSome) |
Lausanne VD |
Massouras, Andreas (Saphetor SA 201604 CEO + Founder before Citigroup + Credit Suisse + Salomon Brothers) |
Chief Executive Officer (CEO) |
Saphetor S.A. (VarSome) |
Lausanne VD |
Romero, Yannick (Saphetor SA 201601– Head Business Development) |
Business Development Manager / Strategy Manager |
Saphetor S.A. (VarSome) |
Lausanne VD |
Tarr, Ian J. (Current BioData 200610– CEO before Thomson Scientific before Current Drugs Ltd) |
Chief Executive Officer (CEO) |
Science Navigation Group |
Genève (Geneva) GE |
Muller, Georges (Seed Biosciences 202302 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Seed Biosciences S.A. |
Epalinges VD |
O’Connell, Alan (Seroba Life Sciences 201702 Partner joined 2003 before Elan Corp + American Biogenetic Sciences) |
Partner (venture partner) |
Seroba (Group) |
Dublin |
Bauer, Ariel (SGS 202401 Group VP Investor Relations, Communications + Sustainability) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Genève (Geneva) GE |
Dabu, Ferdinand (SGS 201011 Global Marketing Director Life Sciences Services R&D/QC) |
Sales Manager / Marketing Manager |
SGS (Group) |
Genève (Geneva) GE |
Dauwalder, Magali (SGS 202307 Media Relations) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Genève (Geneva) GE |
de Buman, Jean-Luc (SGS 201505 Corp Development, Communications + PR) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Genève (Geneva) GE |
du Buman, Jean-Luc (SGS 201609 Corp Developm + Communications + PR) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Genève (Geneva) GE |
Engelen, Julie (SGS 201802 Investor Relations Manager) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Genève (Geneva) GE |
Hediard, Florent (SGS 201610 Life Sciences Marketing Director Agriculture + Food + Life) |
Sales Manager / Marketing Manager |
SGS (Group) |
Genève (Geneva) GE |
Hoenlinger, Sheida (SGS 201610 Director Life Sciences Germany) |
President/Director/Head Business Group/Unit/Division |
SGS (Group) |
Genève (Geneva) GE |
Kirk, Chris (SGS 201011 CEO) |
Chief Executive Officer (CEO) |
SGS (Group) |
Genève (Geneva) GE |
Marriott, Peter (SGS 201012 Global Technical & Accreditation Manager) |
Technical Manager |
SGS (Group) |
Genève (Geneva) GE |
Ng, Frankie (SGS –201505–202403 CEO STEPPED DOWN 3/24) |
Chief Executive Officer (CEO) |
SGS (Group) |
Genève (Geneva) GE |
Picaud, Géraldine (SGS 202403– CEO joined 202312 as CFO before Holcim + Essilor + Safic Alcan + ED&F Man Group) |
Chief Executive Officer (CEO) |
SGS (Group) |
Genève (Geneva) GE |
Reeks, Toby (SGS 202012 SVP Investor Relations + Corporate Communciations + Sustainability) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Genève (Geneva) GE |
Rufenacht, Daniel (SGS 202012 Group VP Corporate Communciations + Sustainability) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Genève (Geneva) GE |
Sansawat, Supreeya (SGS 201012 Global Manager of Food Services) |
n. a. |
SGS (Group) |
Genève (Geneva) GE |
Wacker, Ron (SGS 201106– Global BusDev Manager Food Testing before Danone + Chimera Biotec) |
Business Development Manager / Strategy Manager |
SGS (Group) |
Genève (Geneva) GE |
Catsicas, Stefan (SkyViews Life Science 202012 Managing Partner) |
Managing Partner (investment firm) |
SkyViews Life Science S.A. |
Vaud (Canton) |
Althoff, Gioia (Sophia Genetics 201904 SVP Genomics) |
President/Director/Head Business Group/Unit/Division |
Sophia Genetics (Group) |
Lausanne VD |
Camblong, Jurgi (Sophia Genetics 201407 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Sophia Genetics (Group) |
Lausanne VD |
Hashimoto, Lara (Sophia Genetics 202004– CBO before Roche Diagnostics) |
Chief Business Officer (CBO) |
Sophia Genetics (Group) |
Lausanne VD |
Jiang, Hui (BGI 202002 COO of MGI) |
Chief Operating Officer (COO) |
Sophia Genetics (Group) |
Lausanne VD |
Matillon, Valentin (Sophia Genetics 201801– CFO before Hobart Group + SITA + Electronic Arts + Hewlett-Packard Europe) |
Chief Financial Officer (CFO) |
Sophia Genetics (Group) |
Lausanne VD |
Menu, Philippe (Sophia Genetics 202002– CMO before McKinsey & Company) |
Chief Medical Officer (CMO) |
Sophia Genetics (Group) |
Lausanne VD |
Muken, Ross (Sophia Genetics 202102– CFO before Click Therapeutics 201907– CFO before ISI Group + Deutsche Bank) |
Chief Financial Officer (CFO) |
Sophia Genetics (Group) |
Lausanne VD |
Puylaert, Kevin (Sophia Genetics 202002 VP Business Development) |
Business Development Manager / Strategy Manager |
Sophia Genetics (Group) |
Lausanne VD |
Reymond, Sophie (Sophia Genetics 202002 Media RElations Specialist) |
Public Relations Manager / Investor Relations Manager |
Sophia Genetics (Group) |
Lausanne VD |
Schule, Marylin Mermod (Sophia Genetics 201801– COO joined 201506 as CFO before Benjamin de Rothschild + La Metairie) |
Chief Financial Officer (CFO) |
Sophia Genetics (Group) |
Lausanne VD |
Tsybin, Yuri (Spectroswiss 202211 CEO + Founder before EPFL 201005 Professor) |
Professor |
Spectroswiss (Group) |
Lausanne VD |
Durham, Lynn-Allison (Stalicla 2017– CEO + Founder) |
Chief Executive Officer (CEO) |
Stalicla S.A. |
Genève (Geneva) GE |
Hyvelin, Jean-Marc (Stalicla 202002 COO) |
Chief Operating Officer (COO) |
Stalicla S.A. |
Genève (Geneva) GE |
Steinmetz, Lars (Stanford Univ 201809 Professor + Co-Founder of Sophia Genetics) |
Professor |
Stanford University |
Stanford, CA |
Bahi, Khaled (Stilla Technologies 201911– CFO before Symetis + Fresenius Medical Care) |
Chief Financial Officer (CFO) |
Stilla Technologies (Group) |
Villejuif |
Bozotti, Carlo (STMicroelectronics 200702 Pres + CEO) |
Chief Executive Officer (CEO) |
STMicroelectronics (Group) |
Plan-les-Ouates GE |
Hofmeister, Anton (STMicroelectronics 200509) |
n. a. |
STMicroelectronics (Group) |
Plan-les-Ouates GE |
Lopriore, Stefano (STMicroelectronics 200506) |
n. a. |
STMicroelectronics (Group) |
Plan-les-Ouates GE |
Bairoch, Amos (Swiss Institute of Bioinformatics 2009 Professor) |
Professor |
Swiss Institute of Bioinformatics (SIB) |
Lausanne VD |
Durinx, Christine (VIB 202204– Co-Managing Director before Swiss Institute of Bioinformatics Executive Director) |
Managing Director |
Swiss Institute of Bioinformatics (SIB) |
Lausanne VD |
Jurietti, Emanuela (Switzerland Innovation 202103 Director Marketing + Communications at Biopôle Lausanne) |
Sales Manager / Marketing Manager |
Switzerland Innovation (Group) |
Epalinges VD |
Nahas, Nasri G. (Spinomix 201506 CEO before GeneBio CEO) |
Chief Executive Officer (CEO) |
Switzerland Innovation (Group) |
Epalinges VD |
Fathi, Marc (University Geneva 201008 HUG Toxicology Lab) |
Researcher (university / research institute) |
University of Geneva (Université de Genève, UNIGE) |
Genève (Geneva) GE |
Guillarme, Davy (Univ Geneva 201704) |
Researcher (university / research institute) |
University of Geneva (Université de Genève, UNIGE) |
Genève (Geneva) GE |
Halazonetis, Thanos (Univ Geneva 202004 Professor) |
Professor |
University of Geneva (Université de Genève, UNIGE) |
Genève (Geneva) GE |
Hochstrasser, Denis (University Geneva 201005 Professor HUG Head Dept Genetic and Laboratory Medicine) |
Professor |
University of Geneva (Université de Genève, UNIGE) |
Genève (Geneva) GE |
Hopfgartner, Gérard (Univ Geneva 201003 Professor) |
Professor |
University of Geneva (Université de Genève, UNIGE) |
Genève (Geneva) GE |
Sanchez, Jean-Charles (Univ Geneva 201204 Professor + Director Biomedical Proteomics Research Group) |
Professor |
University of Geneva (Université de Genève, UNIGE) |
Genève (Geneva) GE |
Senatore, Carmine (Univ Geneva 201606 Prof in Dept of Quantum Matter Physics) |
Professor |
University of Geneva (Université de Genève, UNIGE) |
Genève (Geneva) GE |
Augsburger, Marc (CURML-UTCF 201005 Operational Manager) |
n. a. |
University of Lausanne (UNIL) |
Lausanne VD |
Coukos, George (Univ Lausanne 201601 Prof + Director of Ludwig Institute for Cancer Research) |
Professor |
University of Lausanne (UNIL) |
Lausanne VD |
Palazzo, Guido (Univ Lausanne 202309 Prof of Business Ethics) |
Professor |
University of Lausanne (UNIL) |
Lausanne VD |
Rochat, Bertrand (Univ Lausanne 201410 CHUV) |
n. a. |
University of Lausanne (UNIL) |
Lausanne VD |
Drumm, Joshua (Valneva 202108 VP Global Investor Relations before AC Immune) |
Public Relations Manager / Investor Relations Manager |
Valneva (Group) |
Nantes |
Tieng, Vannary (Vanarix 202208 CEO + Founder) |
Chief Executive Officer (CEO) |
Vanarix S.A. |
Lausanne VD |
Dugi, Klaus (Vandria 2021– CEO before Boehringer + Ferring) |
Chief Executive Officer (CEO) |
Vandria S.A. |
Lausanne VD |
Harboe-Schmidt, Peter (Vandria 202312 Head of Business Development + Finance) |
Business Development Manager / Strategy Manager |
Vandria S.A. |
Lausanne VD |
Schorsch, Susanne K. (Verve Ventures 202204 Venture Investor before BASF) |
Investment Manager |
Verve Capital Partners AG (Verve Ventures, formerly investiere.ch) |
Zug ZG |
Béduer, Amélie (Volumina Medical 202403 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Volumina Medical S.A. |
Epalinges VD |
Daniels, Graeme (Andrew Alliance 201809– VP Business Development before ADInstruments + Cytocentrics + Tecan UK) |
Business Development Manager / Strategy Manager |
Waters (Group) |
Genève (Geneva) GE |
Zucchelli, Piero (Andrew Alliance 201806 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Waters (Group) |
Genève (Geneva) GE |
Keywood, Charlotte (Zambon 201603 Head RnD before Addex Pharma CMO) |
Research & Development Manager |
Zambon (Group) |
Bresso (MI) |
Schier, Robert (Zürcher Kantonalbank 201909 Investment Director PE/V Health-Tech at Swisscanto Invest) |
Investment Manager |
Zürcher Kantonalbank (ZKB) |
Switzerland_oo |